Histone Deacetylase 7 Promotes Toll-like Receptor 4-dependent Proinflammatory Gene Expression in Macrophages*

  1. Matthew J. Sweet23
  1. From the Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, University of Queensland, Queensland 4072, Australia and
  2. the §Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Roslin EH25 9PS Scotland, United Kingdom
  1. 3 To whom correspondence should be addressed: The University of Queensland, Institute for Molecular Bioscience, Qld 4072, Australia. Tel.: 61-7-3346-2082; Fax: 61-7-3346-2101; E-mail: m.sweet{at}imb.uq.edu.au.

Background: Histone deacetylase (HDAC) inhibitors reduce LPS-induced inflammatory mediator production from macrophages, but the relevant HDAC targets are unknown.

Results: A specific isoform of Hdac7 amplifies expression of LPS-inducible genes via a HIF-1α-dependent mechanism in macrophages.

Conclusion: The class IIa HDAC Hdac7 promotes inflammatory responses in macrophages.

Significance: Hdac7 may be a viable target for developing new anti-inflammatory drugs.

Abstract

Broad-spectrum inhibitors of histone deacetylases (HDACs) constrain Toll-like receptor (TLR)-inducible production of key proinflammatory mediators. Here we investigated HDAC-dependent inflammatory responses in mouse macrophages. Of the classical Hdacs, Hdac7 was expressed at elevated levels in inflammatory macrophages (thioglycollate-elicited peritoneal macrophages) as compared with bone marrow-derived macrophages and the RAW264 cell line. Overexpression of a specific, alternatively spliced isoform of Hdac7 lacking the N-terminal 22 amino acids (Hdac7-u), but not the Refseq Hdac7 (Hdac7-s), promoted LPS-inducible expression of Hdac-dependent genes (Edn1, Il-12p40, and Il-6) in RAW264 cells. A novel class IIa-selective HDAC inhibitor reduced recombinant human HDAC7 enzyme activity as well as TLR-induced production of inflammatory mediators in thioglycollate-elicited peritoneal macrophages. Both LPS and Hdac7-u up-regulated the activity of the Edn1 promoter in an HDAC-dependent fashion in RAW264 cells. A hypoxia-inducible factor (HIF) 1 binding site in this promoter was required for HDAC-dependent TLR-inducible promoter activity and for Hdac7- and HIF-1α-mediated trans-activation. Coimmunoprecipitation assays showed that both Hdac7-u and Hdac7-s interacted with HIF-1α, whereas only Hdac7-s interacted with the transcriptional repressor CtBP1. Thus, Hdac7-u positively regulates HIF-1α-dependent TLR signaling in macrophages, whereas an interaction with CtBP1 likely prevents Hdac7-s from exerting this effect. Hdac7 may represent a potential inflammatory disease target.

Footnotes

  • 1 Supported by Australian Research Council Federation Fellowship FF0668733 and National Health and Medical Research Council Senior Principal Research Fellowship APP1027369.

  • 2 Supported by Australian Research Council Future Fellowship FT100100657 and honorary National Health and Medical Research Council of Australia Senior Research Fellowship APP1003470.

  • * This work was supported in part by National Health and Medical Research Council of Australia Grants ID 569735 and APP1047921 and by Cancer Council Queensland Grant ID 511205.

  • Graphic This article contains supplemental Fig. S1.

  • Received June 24, 2013.
Table of Contents

Submit your work to JBC.

You'll be in good company.